Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
---|---|---|---|---|---|
EP2520301B2 | 03 Mar, 2021 | Parenteral Pharmaceutical Formulation In Suspension, Having Sustained Release, In Low And Ultralow Dosage, In Hormonal Therapy In The Climacteric Syndrome | NA | 1 |